렘수면행동장애의 치료
Treatment of REM Sleep Behavior Disorder
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
REM sleep behavior disorder (RBD) is clinically characterized by the intermittent loss of normal skeletal muscle atonia during rapid eye movement (REM) sleep with the appearance of elaborate motor activity associated with dream mentation. Clonazepam, a sedating benzodiazepine, is currently regarded as the treatment of choice for RBD. In patients with contraindications to clonazepam, in those unresponsive to clonazepam, or in whom tolerance or serious side effects are observed, a therapeutic trial with melatonin up to 12 mg is recommended. The effect of acetylcholinesterase inhibitors and dopaminergics on RBD symptoms needs future validation. There is no clear evidence of beneficial effect of bilateral subthalamic nucleus stimulation despite the improvement of the sleep architecture
Abstract
REM sleep behavior disorder (RBD) is clinically characterized by the intermittent loss of normal skeletal muscle atonia during rapid eye movement (REM) sleep with the appearance of elaborate motor activity associated with dream mentation. Clonazepam, a sedating benzodiazepine, is currently regarded as the treatment of choice for RBD. In patients with contraindications to clonazepam, in those unresponsive to clonazepam, or in whom tolerance or serious side effects are observed, a therapeutic trial with melatonin up to 12 mg is recommended. The effect of acetylcholinesterase inhibitors and dopaminergics on RBD symptoms needs future validation. There is no clear evidence of beneficial effect of bilateral subthalamic nucleus stimulation despite the improvement of the sleep architecture
참고문헌 (29)
- Atlas Task Force of the American Sleep Disorders Association, "The International Classification of Sleep Disorders -Diagnostic and Coding Manual", ~ (2005)
- Nightingale S, "The association between narcolepsy and REM behavior disorder (RBD)", Sleep Med, 6, pp.253~256 (2005)
- Boeve BF, "Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy", Mov Disord, 16, pp.622~630 (2001)
- Schenck CH, "REM behavior disorder (RBD): delayed emergence of parkinsonism and", or dementia in 65% of older men initially diagnosed with idiopathic RBD, and an analysis of the minimum and maximum tonic and, Sleep, pp.2003, 26(Suppl)[DOI]
- Schenck CH, "REM sleep behaviour disorder: an update on a series of 96 patients and a review of the world literature", J Sleep Res, 2, pp.224~231 (1993)
- Olson EJ, "Rapid eye movement sleep behavior disorder: demographic, clinical and laboratory findings in 93 cases", Brain, 123, pp.331~339 (2000)
- Lapierre O, "Polysomnographic features of REM sleep behavior disorder: development of a scoring method", Neurology, 42, pp.1371~1374 (1992)
- Schenck CH, "Polysomnographic, neurologic, psychiatric, and clinical outcome report on 70 consecutive cases with REM sleep behavior disorder (RBD) : sustained clonazepam efficacy in 89.5% of 57 treated patients", Cleve Clin J Med, 57(Suppl), pp.S9~S23 (1990)
- Kunz D, "Melatonin effects in a patient with severe REM sleep behavior disorder: case report and theoretical considerations", Neuropsychobiology, 36, pp.211~214 (1997)
- Takeuchi N, "Melatonin therapy for REM sleep behavior disorder", Psychiatry Clin Neurosciences, 55, pp.267~269 (2001)
- Boeve BF, "Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients", Sleep Med, 4(4), pp.281~284 (2003)
- Eisensehr I, "Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson’s disease and controls", Brain, 123, pp.1155~1160 (2000)
- Albin RL, "Decreased striatal dopaminergic innervation in REM sleep behavior disorder", Neurology, 55, pp.1410~1412 (2000)
- Fantini ML, "Periodic leg movements in REM sleep behavior disorder and related autonomic and EEG activation", Neurology, 59, pp.1889~1894 (2002)
- Fantini ML, "The effects of pramipexole in REM sleep behavior disorder", Neurology, 61, pp.1418~1420 (2003)
- Kumru H, "Lack of effects of pramipexole on REM sleep behavior disorder in Parkinson disease", Sleep, 31(10), pp.1418~1421 (2008)
- Tan A, "Rapid eye movement sleep behavior disorder preceding Parkinson’s disease with therapeutic response to levodopa", Mov Disord, 11, pp.214~216 (1996)
- Bamford CR, "Carbamazepine in REM sleep behavior disorder", Sleep, 16(1), pp.33~34 (1993)
- Matsumoto M, "The effects of imipramine on REM sleep behavior disorder in 3 cases", Sleep Res, 20A, pp.351~ (1991)
- Ringman JM, "Treatment of REM sleep behavior disorder with donepezil : A report of three cases", Neurology, 55(6), pp.870~871 (2000)
- Massironi G, "Drug treatment of REM sleep behavior disorders in dementia with Lewy bodies", Int Psychogeriatr, 15, pp.377~383 (2003)
- Shiromani PJ, "Acetylcholine and the regulation of REM sleep: basic mechanisms and clinical implications for affective illness and narcolepsy", Ann Rev Pharmacol Toxicol, 27, pp.137~156 (1987)
- Grace JB, "A comparison of sleep profiles in patients with dementia with Lewy bodies and Alzheimer’s disease", Int J Geriatr Psychiatry, 15, pp.1028~1033 (2000)
- Iranzo A, "Sleep symptoms and polysomnographic architecture in advanced Parkinson’s disease after chronic bilateral sybthalamic stimulation", J Neurol Neurosurg Psychiatry, 72, pp.661~664 (2002)
- Arnulf I, "Improvement of sleep architecture in PD with subthalamic nucleus stimulation", Neurology, 55, pp.1732~1734 (2000)
- Bental E, "Severe hypermotility during sleep in treatment of cataplexy with clomipramine", Isr J Med Sci, 15, pp.607~609 (1979)
- Louden MB, "Activation by selegiline (Eldepryle) of REM sleep behavior disorder in parkinsonism", W V Med J, 91, pp.101~ (1995)
- Onofrj M, "Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism", Neurology, 60, pp.113~115 (2003)
- Vorona RD, "Exacerbation of REM sleep behavior disorder by chocolate ingestion: a case report", Sleep Med, 3, pp.365~367 (2002)